Delivery Order SPE2DB24D9144-SPE2DB24FCMJW

Award Date 8/13/24
Potential Completion Date 9/4/24
Potential Value $8.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of the Department of Defense (DoD) and Department of Veterans Affairs (VA) health facilities nationwide. The $11,089.08 firm fixed-price delivery order is issued under a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency's Medical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of various pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $18,568.80 firm fixed-price delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, which runs through December 31, 2025....
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides a range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $74,135.50 firm fixed-price delivery order, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, covers a comprehensive array of medications, including branded and generic prescription drugs,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The contract, a firm fixed-price delivery order worth $8,559.67, was awarded by the Defense Logistics Agency (DLA) under the SPE2DB program, a multi-year indefinite delivery contract...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides a range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities and VA medical centers. The $33,614.63 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, which manages procurement of pharmaceuticals for the Department of Defense (DoD)....
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The contract, awarded by the Defense Logistics Agency (DLA), is a firm fixed-price delivery order with a ceiling value of $11,840.00 and an ultimate completion date of April 25, 2024. It is part of a larger...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) medical facilities. The $1,278.20 firm fixed-price delivery order, with an ultimate completion date of July 25, 2024, is part of a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program. This IDC...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of a wide range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract, valued at $11,840.66, is a firm fixed-price delivery order issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) worth up to $499,999,999. The IDC,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of a variety of pharmaceutical items, including injectable medications, tablets, creams, and specialty drugs, to support the medical supply needs of U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $1,368.39 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain program,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order with a ceiling value of $1,278.20. The contract was awarded by the Defense Logistics Agency (DLA), specifically the Medical Supply Chain division, to provide a wide range of pharmaceutical products and medical supplies to the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities nationwide. The contract is part of a larger indefinite...
  • SPE2DB24D9144
    Indefinite Delivery Contract
  • SPE2DB24D9144-SPE2DB24FCMJW
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides a range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $8,509.92 firm fixed-price delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, which runs through December 31, 2025. This IDC allows the DLA to issue delivery orders for a comprehensive array of pharmaceutical items, from common medications to specialized drugs and medical supplies, to fulfill the recurring medical needs of military personnel and their dependents. The contract has no set-aside designation, leveraging DMS Pharmaceutical Group's woman-owned small business status to secure direct awards for the DoD's pharmaceutical Prime Vendor programs globally.

Generated 11/12/24, 9:11 AM